Engineered Hematopoietic Stem Cells as Therapeutics for Hemophilia A.
作者信息
Zakas Philip M, Spencer H Trent, Doering Christopher B
机构信息
Graduate Program in Molecular and Systems Pharmacology, Graduate Division of Biological and Biomedical Sciences, Emory University.
Aflac Cancer Center and Blood Disorders Service, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
出版信息
J Genet Syndr Gene Ther. 2011 Nov 16;1(3). doi: 10.4172/2157-7412.S1-003.
Abstract
摘要
相似文献
1
Engineered Hematopoietic Stem Cells as Therapeutics for Hemophilia A.工程化造血干细胞作为甲型血友病的治疗手段
J Genet Syndr Gene Ther. 2011 Nov 16;1(3). doi: 10.4172/2157-7412.S1-003.
2
Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.编码猪源因子VIII的造血干细胞在已存在因子VIII免疫的甲型血友病小鼠中诱导促凝血活性。
Mol Ther. 2007 Jun;15(6):1093-9. doi: 10.1038/sj.mt.6300146. Epub 2007 Mar 27.
3
Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A.经基因修饰的造血干细胞移植治疗血友病 A 后因子 VIII 表达的功能方面。
J Gene Med. 2010 Apr;12(4):333-44. doi: 10.1002/jgm.1442.
4
Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.用于血友病 A 的造血干细胞和祖细胞生物工程因子 VIII 慢病毒载体基因治疗的临床前开发。
Hum Gene Ther. 2018 Oct;29(10):1183-1201. doi: 10.1089/hum.2018.137.
5
Replacing bad (F)actors: hemophilia.取代不良（因）素：血友病。
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):461-7. doi: 10.1182/asheducation-2014.1.461. Epub 2014 Nov 18.
6
Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A.用于A型血友病的改良VIII因子分子及新基因转移方法的研发。
Curr Gene Ther. 2003 Feb;3(1):27-41. doi: 10.2174/1566523033347417.
7
Effects of FVIII immunity on hepatocyte and hematopoietic stem cell-directed gene therapy of murine hemophilia A.FVIII免疫对小鼠A型血友病肝细胞和造血干细胞定向基因治疗的影响。
Mol Ther Methods Clin Dev. 2016 Feb 10;3:15056. doi: 10.1038/mtm.2015.56. eCollection 2016.
8
Correction of murine hemophilia A by hematopoietic stem cell gene therapy.通过造血干细胞基因疗法纠正小鼠血友病A。
Mol Ther. 2005 Dec;12(6):1034-42. doi: 10.1016/j.ymthe.2005.09.007. Epub 2005 Oct 12.
9
Designing Motif-Engineered Receptors To Elucidate Signaling Molecules Important for Proliferation of Hematopoietic Stem Cells.设计基序工程化受体以阐明对造血干细胞增殖重要的信号分子。
ACS Synth Biol. 2018 Jul 20;7(7):1709-1714. doi: 10.1021/acssynbio.8b00163. Epub 2018 Jun 21.
10
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.用于血友病基因治疗的蛋白质工程凝血因子
Mol Ther Methods Clin Dev. 2018 Dec 31;12:184-201. doi: 10.1016/j.omtm.2018.12.007. eCollection 2019 Mar 15.
引用本文的文献
1
Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII.比较不同的基因添加策略，以修饰胎盘来源的间充质基质细胞来产生 FVIII。
Front Immunol. 2022 Dec 15;13:954984. doi: 10.3389/fimmu.2022.954984. eCollection 2022.
2
HDAd5/35 Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells.表达抗CRISPR肽的HDAd5/35腺病毒载体可降低CRISPR/Cas9在人类造血干细胞中的毒性。
Mol Ther Methods Clin Dev. 2018 May 1;9:390-401. doi: 10.1016/j.omtm.2018.04.008. eCollection 2018 Jun 15.
3
The Utilization of Rehabilitation in Patients with Hemophilia A in Taiwan: A Nationwide Population-Based Study.台湾地区甲型血友病患者康复治疗的利用情况：一项基于全国人口的研究。
PLoS One. 2016 Sep 30;11(9):e0164009. doi: 10.1371/journal.pone.0164009. eCollection 2016.
本文引用的文献
1
Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC.通过产后腹腔内移植表达 FVIII 的 MSC 纠正绵羊血友病 A 的表型。
Exp Hematol. 2011 Dec;39(12):1124-1135.e4. doi: 10.1016/j.exphem.2011.09.001. Epub 2011 Sep 8.
2
Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.腺苷脱氨酶缺乏症严重联合免疫缺陷症的造血干细胞基因治疗可实现长期免疫恢复和代谢纠正。
Sci Transl Med. 2011 Aug 24;3(97):97ra80. doi: 10.1126/scitranslmed.3002716.
3
Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.基因治疗 X 连锁重症联合免疫缺陷后多克隆 T 细胞 repertoire 的长期持久性。
Sci Transl Med. 2011 Aug 24;3(97):97ra79. doi: 10.1126/scitranslmed.3002715.
4
Site-specific integration and tailoring of cassette design for sustainable gene transfer.位点特异性整合和盒式设计的定制化用于可持续基因转移。
Nat Methods. 2011 Aug 21;8(10):861-9. doi: 10.1038/nmeth.1674.
5
Targeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugate.经系统给予肽核酸-肽缀合物后对小鼠造血祖细胞进行的靶向基因修饰。
Mol Ther. 2012 Jan;20(1):109-18. doi: 10.1038/mt.2011.163. Epub 2011 Aug 9.
6
In vivo genome editing restores haemostasis in a mouse model of haemophilia.体内基因组编辑恢复血友病小鼠模型的止血功能。
Nature. 2011 Jun 26;475(7355):217-21. doi: 10.1038/nature10177.
7
Enhanced biosynthesis of coagulation factor VIII through diminished engagement of the unfolded protein response.通过减少未折叠蛋白反应的结合来增强凝血因子 VIII 的生物合成。
J Biol Chem. 2011 Jul 8;286(27):24451-7. doi: 10.1074/jbc.M111.238758. Epub 2011 May 23.
8
Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs.血小板基因治疗可改善整合素 αIIbbeta3 缺陷犬的止血功能。
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9583-8. doi: 10.1073/pnas.1016394108. Epub 2011 May 23.
9
Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.造血干细胞来源的 B 细胞递送的因子 VIII 纠正了血友病 A 小鼠的表型。
Thromb Haemost. 2011 Apr;105(4):676-87. doi: 10.1160/TH10-11-0725. Epub 2011 Jan 25.
10
Advancements in gene transfer-based therapy for hemophilia A.基于基因转移的甲型血友病治疗进展。
Expert Rev Hematol. 2009 Dec;2(6):673-683. doi: 10.1586/EHM.09.63.
Zotero 插件